Neogen Chemicals Q1 FY27 Net Profit Rises 66.8% to ₹171.1 Million

THANE, India — Neogen Chemicals Limited announced its consolidated financial results for the quarter ended June 30, 2026, recording a total revenue from operations of ₹2,502.9 million (approx. ₹2.5 billion). The specialty chemical manufacturer reported a consolidated net profit of ₹171.1 million, reflecting robust demand across its core operating segments and improved operational efficiencies compared to previous reporting periods.

The performance highlights recovery and momentum following past disruptions at its manufacturing sites. Along with its quarterly earnings, the Board of Directors granted in-principle approval to raise up to ₹600 crore through qualified institutional placements or other permissible equity instruments to support future growth plans.

Detailed Financial Performance and QoQ / YoY Comparisons

Neogen Chemicals posted positive growth across both year-on-year (YoY) and quarter-on-quarter (QoQ) metrics.

Revenue and Operating Performance

Consolidated revenue from operations for Q1 FY27 stood at ₹250.29 crore (₹2,502.9 million), representing a 34% increase from ₹186.73 crore in the corresponding period of the previous fiscal year (Q1 FY26). Sequentially, revenue grew 1.5% compared to ₹246.56 crore reported in Q4 FY26.

Total income, including other income of ₹3.86 crore, reached ₹254.15 crore for the quarter.

Profitability Ratios

• Net Profit (PAT): Consolidated profit after tax reached ₹17.11 crore (₹171.1 million) for Q1 FY27, up 66.8% YoY compared to ₹10.26 crore in Q1 FY26. Profit after tax expanded 50.2% sequentially from ₹11.39 crore in Q4 FY26.

• Profit Before Tax (PBT): Consolidated PBT rose to ₹23.28 crore, compared to ₹14.29 crore in Q1 FY26 and ₹15.85 crore in Q4 FY26.

• Operating Margin: The consolidated operating margin improved to 19.35% for Q1 FY27, compared to 15.96% in Q1 FY26 and 17.82% in Q4 FY26.

• Net Profit Margin: Net profit margin improved to 6.83% for the quarter, up from 3.33% in Q1 FY26 and 4.62% in Q4 FY26.

• Earnings Per Share (EPS): Basic and diluted EPS for the quarter rose to ₹6.29 per share, compared to ₹3.89 in Q1 FY26 and ₹4.32 in Q4 FY26.

Key Consolidated Financial Summary Table

Corporate Developments and Strategic Fund Raising

The Board of Directors approved several regulatory proposals alongside the quarterly results:

1. Capital Raise: The board granted in-principle approval to raise funds up to ₹600 crore in one or more tranches via equity shares, Qualified Institutional Placements (QIP), or other permissible modes, subject to shareholder and regulatory approvals.

2. Preferential Allotment Status: Neogen confirmed the full utilization of ₹161 crore raised via a preferential allotment completed on April 18, 2026, to promoter group entity Cadamba Solutions Private Limited, with zero deviation in fund usage.

3. Internal Auditor Appointment: CNK & Associates LLP was appointed as the internal auditor of the company for FY 2026–27.

4. Credit Rating Update: CRISIL Ratings revised the long-term rating to "CRISIL A-/Negative" and short-term rating to "CRISIL A2" on July 17, 2026. Consequently, the coupon rate on the company's ₹200 crore listed Non-Convertible Debentures (NCDs) adjusted from 10.50% p.a. to 11.00% p.a. effective July 17, 2026.

Official Sources Section

Statements, regulatory filings, and financial metrics were disclosed pursuant to Regulations 33, 32, 51, and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The official results were verified by statutory auditors M/s Chandabhoy & Jassoobhoy and approved by Neogen Chemicals Limited's Board of Directors during their meeting on July 24, 2026.

Outbound regulatory compliance submissions and financial disclosures are maintained on the official stock exchange portals:

• Securities filings at the
  Bombay Stock Exchange (BSE)

• Equities listing data at the
  National Stock Exchange of India (NSE)

• Corporate releases on the official portal of
  Neogen Chemicals Limited

Quote Section

"According to official regulatory filings approved by the Board of Directors, Neogen Chemicals Limited achieved consolidated revenue from operations of ₹250.29 crore with a net profit after tax of ₹17.11 crore for the first quarter of FY27," the company stated in its SEBI submission.

Organizers and board members stated that the proposed ₹600 crore fund raise will enable the company to maintain financial flexibility for ongoing expansion projects across its specialty chemicals and battery material business verticals.

Why It Matters

The improvement in Neogen Chemicals' Q1 FY27 financial performance signals stabilization in specialty chemical demand dynamics. The company's expansion into battery chemicals, backed by strategic capital raising initiatives, positions it to capture market opportunities in high-growth industrial sectors. Investors and market participants continue to monitor the company's capital allocation strategies and cash flow recoveries as production continues to scale up across facilities.

Key Facts at a Glance

• Q1 FY27 Operations Revenue: ₹250.29 crore (₹2.5 billion), representing a 34% YoY increase.

• Q1 FY27 Net Profit: ₹17.11 crore (₹171.1 million), up 66.8% YoY.

• Operating Margin: Expanded to 19.35% from 15.96% in Q1 FY26.

• Proposed Capital Raise: In-principle approval granted for raising up to ₹600 crore.

• Preferential Allotment: ₹161 crore fully utilized without deviation for subsidiary investments, working capital, and corporate purposes.

Frequently Asked Questions (FAQ)

What were Neogen Chemicals' Q1 FY27 earnings?

Neogen Chemicals recorded consolidated revenue from operations of ₹250.29 crore and a net profit after tax of ₹17.11 crore for Q1 FY27.

How did Q1 FY27 results compare to Q1 FY26?

Revenue from operations increased 34% from ₹186.73 crore in Q1 FY26, while net profit grew 66.8% from ₹10.26 crore in Q1 FY26.

Why is Neogen Chemicals raising ₹600 crore?

The Board granted in-principle approval to raise up to ₹600 crore through qualified institutional placements or equity issuances to support corporate growth, operational requirements, and strategic projects.

Source: Neogen Chemicals Limited Financial Results Disclosure (SEBI Submission), BSE India Announcements, and NSE India Announcements.